The phosphoinositide 3-kinase (PI3K)/AKT axis is pivotal in the development of cancer (1, 2), with oncogenic genetic alterations in PI3Kα occurring in approximately 14% of cancers (3, 4). This evidence concerns the gene AKT1 and cancer.